Au­robindo Phar­ma’s US branch is­sues a re­call of a gener­ic med­i­cine

In­di­an gener­ics man­u­fac­tur­er Au­robindo is hav­ing to pull an­oth­er prod­uct off the shelves.

Ac­cord­ing to the FDA, the com­pa­ny’s US branch, Au­robindo Phar­ma USA, has …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.